Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

Pfizer has raised £2.5 billion by offloading its remaining 7.3% stake in Haleon, the Panadol and Sensodyne business it used ...

Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...

Affordability used to matter once but not so much in the post-COVID era, and the nation seems to have lost its fear of debt ...

Besides, such critics unmask themselves as acting in bad faith by failing to mention the cases of Ekiti and Plateau States where then-President Olusegun Obasanjo declared a state of emergency and ...

Christopher Luxon has jammed everything humanly possible into his week in India. Laura Walters shares a behind-the-scenes ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...

SA women with endometriosis are experiencing long delays in diagnosis and treatment because of problems accessing medical ...

Only one in ten treatments for back pain actually work, and those that do are barely better than a placebo, a study from the ...

Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...

Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing ...